Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

Healthcare Biotechnology
StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease... see more

Recent & Breaking News (TSX:SZLS)

StageZero to Issue Q4 2022 Financial Results and Hold Conference Call on Thursday March 30

Newsfile March 29, 2023

Results from METRICs Study Informs Expansion of StageZero's New Care Oncology Protocol

Newsfile February 15, 2023

StageZero Life Sciences Announces Change of Date of Special Meeting of Shareholders; Will Combine with AGM in Q2 2023

Newsfile February 2, 2023

StageZero Life Sciences Announces Extension of Warrants Expiring in January 2023

Accesswire January 12, 2023

StageZero (TSX:SZLS) signs $25M agreement

Caroline Egan  November 21, 2022

StageZero Life Sciences Ltd. Secures CAD $25 Million Capital Commitment from GEM Global Yield LLC SCS

Accesswire November 21, 2022

StageZero Life Sciences, Ltd Announces Q3 2022 Financial Results and Operational Update

Accesswire November 15, 2022

StageZero to Hold Q3 2022 Operational and Financial Results Conference Call on Tuesday November 15, 2022

Accesswire November 11, 2022

StageZero Life Sciences Announces Closing of Convertible Debenture Financing

Accesswire August 18, 2022

StageZero (TSX:SZLS) announces program to help employers improve cancer journeys

Caroline Egan  August 18, 2022

StageZero Announces Solutions for Employers to Help Improve Cancer Outcomes

Accesswire August 18, 2022

StageZero Life Sciences, Ltd Announces Q2 2022 Financial Results and Operational Update

Accesswire August 16, 2022

StageZero to Hold Q2 2022 Operational and Financial Results Conference Call on Tuesday August 16, 2022

Accesswire August 12, 2022

StageZero Life Sciences Announces Results on Resolutions at Annual and Special Meeting

Accesswire June 28, 2022

StageZero Life Sciences Announces Resignation of CFO

Accesswire May 26, 2022

StageZero Life Sciences Partners with DiagnoseAtHome to Offer Aristotle(R) Multi-Cancer Blood Test in Canada and USA

Accesswire May 25, 2022

StageZero Life Sciences, Ltd Announces Q1 2022 Financial Results and Operational Update

Accesswire May 17, 2022

StageZero (TSX:SZLS) expands its cancer diagnostic aid programs

Caroline Egan  May 16, 2022

StageZero Life Sciences Launches COC Plus Worldwide

Accesswire May 15, 2022

StageZero to Issue Q1 2022 Financial Results and Hold Conference Call on Tuesday May 17

Accesswire May 13, 2022